Aliko Dangote plans to list shares of his oil-refining company on multiple African stock exchanges to increase market depth.

Regeneron to invest $27 billion in pharmaceutical manufacturing, US President Donald Trump announces. The investment marks a significant expansion for the company's production capabilities.

Regeneron Pharmaceuticals plans to invest $27 billion into its pharmaceutical manufacturing operations, according to US President Donald Trump.

UPDATE: President Donald Trump announces 17 major pharmaceutical companies have agreed to sell drugs to American patients at the lowest prices globally. The firms represent 80% of the branded drug market.

President Donald Trump announced that 17 major pharmaceutical companies, accounting for 80% of the branded drug market, have agreed to sell medications to American patients at the lowest global prices.

President Donald Trump says Regeneron has agreed to provide medications at the lowest available international rates.

President Donald Trump announced that Regeneron has agreed to supply medications at the lowest available international rates.

President Donald Trump says Regeneron has agreed to offer prescription drugs at most-favored-nation prices. The agreement marks a shift in pharmaceutical pricing strategy for the company.

President Donald Trump announced that Regeneron has agreed to provide prescription drugs at most-favored-nation prices.